Type I interferon governs immunometabolic checkpoints that coordinate inflammation during Staphylococcal infection

Mack B Reynolds,Benjamin Klein,Michael J McFadden,Norah K Judge,Hannah E Navarrete,Britton C Michmerhuizen,Dominik Awad,Tracey L Schultz,Paul W Harms,Li Zhang,Teresa R O'Meara,Jonathan Z Sexton,Costas A Lyssiotis,J Michelle Kahlenberg,Mary X O'Riordan
DOI: https://doi.org/10.1016/j.celrep.2024.114607
2024-08-27
Abstract:Macrophage metabolic plasticity is central to inflammatory programming, yet mechanisms of coordinating metabolic and inflammatory programs during infection are poorly defined. Here, we show that type I interferon (IFN) temporally guides metabolic control of inflammation during methicillin-resistant Staphylococcus aureus (MRSA) infection. We find that staggered Toll-like receptor and type I IFN signaling in macrophages permit a transient energetic state of combined oxidative phosphorylation (OXPHOS) and aerobic glycolysis followed by inducible nitric oxide synthase (iNOS)-mediated OXPHOS disruption. This disruption promotes type I IFN, suppressing other pro-inflammatory cytokines, notably interleukin-1β. Upon infection, iNOS expression peaks at 24 h, followed by lactate-driven Nos2 repression via histone lactylation. Type I IFN pre-conditioning prolongs infection-induced iNOS expression, amplifying type I IFN. Cutaneous MRSA infection in mice constitutively expressing epidermal type I IFN results in elevated iNOS levels, impaired wound healing, vasculopathy, and lung infection. Thus, kinetically regulated type I IFN signaling coordinates immunometabolic checkpoints that control infection-induced inflammation.
What problem does this paper attempt to address?